Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 07:16 PM EDT
Marker Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 13.69M | 19.19M | 9M | 7.8M | 11.32M | 15.11M | 17.47M | 18.12M | 6.4M | 11.78M | 18.08M | 25.82M | 28.64M | 42.35M | 48.71M | 57.22M | 64.51M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 2.46M | 2.35M | 744.41K | 2.49M | 1.85M | n/a | 83.31K | 1.75M | 2.08M | 2.4M | 1.68M | 627.63K | 2.19K | 237.00 | 243.00 | 286.00 | 1M |
Inventory | n/a | n/a | n/a | -1.38M | n/a | n/a | n/a | n/a | -1M | n/a | -1.68M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 841.29K | 483.72K | 744.41K | 1.38M | 917.01K | 988.13K | 1.93M | 2.09M | n/a | 585.84K | n/a | 2.83M | 181.86K | 1.15M | 2.7M | 2.8M | 1.96M |
Total Current Assets | 16.99M | 22.02M | 10.91M | 11.68M | 14.09M | 17.13M | 19.49M | 21.96M | 10.91M | 16.62M | 22.42M | 29.28M | 31.02M | 45.98M | 51.41M | 60.02M | 67.47M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.03M | 17.8M | 18.69M | 23.04M | 23.94M | 22.15M | 20.53M | 20.45M | 20.89M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.03M | 17.8M | 18.69M | 23.04M | 23.94M | 22.15M | 20.53M | 20.45M | 20.89M |
Total Assets | 16.99M | 22.02M | 10.91M | 11.68M | 14.09M | 17.13M | 19.49M | 21.96M | 27.94M | 34.42M | 41.11M | 52.32M | 54.96M | 68.14M | 71.94M | 80.47M | 88.36M |
Account Payables | 1.3M | 1.07M | 1.9M | 1.08M | 848.03K | 961K | 429.1K | 1.33M | 2.86M | 1.1M | 2.02M | 1.77M | 5.02M | 5.14M | 2.33M | 2.04M | 1.89M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 107.53K | n/a | n/a | 2.5M | 5.05M | 8M | 181.86K | 1.15M | 5.32M | 3.06M | 1.79M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 490.45K | 738.39K | 683.97K | n/a | 581.59K | 558.66K | 473.08K |
Other Current Liabilities | 44.07K | 86.95K | 1.52M | 775.24K | 1.04M | 1.84M | 1.87M | 980.9K | 1.22M | 1.31M | 1.82M | 826.86K | 901.71K | 3.94M | 3.27M | 1.4M | 354.18K |
Total Current Liabilities | 2.5M | 3.46M | 3.46M | 1.97M | 2.3M | 3.07M | 2.78M | 2.92M | 5.2M | 7.78M | 11.29M | 13.47M | 8.21M | 12.9M | 8.23M | 5.66M | 4.15M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.23M | 10.82M | 11.04M | n/a | 11.43M | 11.57M | 11.72M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.23M | -10.82M | -11.04M | n/a | -11.43M | -11.57M | -11.72M |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.82M | 7.04M | 7.23M | 10.82M | 11.04M | 11.25M | 11.43M | 11.57M | 11.72M |
Total Liabilities | 2.5M | 3.46M | 3.46M | 1.97M | 2.3M | 3.07M | 2.78M | 2.92M | 12.03M | 14.82M | 18.51M | 24.29M | 19.25M | 24.15M | 19.66M | 17.23M | 15.87M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.49M | 7.62M | 7.72M | 11.56M | 11.72M | 11.87M | 12.01M | 12.13M | 12.19M |
Common Stock | 11.21K | 10.71K | 8.92K | 8.92K | 8.91K | 8.89K | 8.89K | 8.8K | 8.8K | 8.41K | 83.6K | 83.6K | 83.45K | 83.08K | 83.08K | 83.08K | 83.01K |
Retained Earnings | -451.46M | -447.02M | -443.18M | -440.87M | -438.68M | -436.29M | -433.48M | -430.5M | -433.02M | -428.05M | -424.19M | -417.27M | -408.03M | -398.12M | -388.36M | -375.93M | -365.02M |
Comprehensive Income | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a |
Shareholders Equity | 14.49M | 18.56M | 7.45M | 9.7M | 11.79M | 14.05M | 16.71M | 19.03M | 15.91M | 19.6M | 22.6M | 28.03M | 35.71M | 43.99M | 52.28M | 63.24M | 72.49M |
Total Investments | n/a | 19,192.4B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |